Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Dow
Merck
McKinsey
Boehringer Ingelheim

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: galantamine hydrobromide

See Plans and Pricing

« Back to Dashboard

galantamine hydrobromide Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Ranbaxy galantamine hydrobromide 077588 8MG TABLET; ORAL
Sun Pharm Inds galantamine hydrobromide 077592 12MG TABLET; ORAL
Ranbaxy galantamine hydrobromide 077588 12MG TABLET; ORAL
Sun Pharm Inds galantamine hydrobromide 077592 8MG TABLET; ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Boehringer Ingelheim
Dow
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.